Similar articles

• Why is the mortality of dialysis patients in the United States much higher than the rest of the world?

  Foley RN, Hakim RM. Foley RN, et al. J Am Soc Nephrol. 2009 Jul;20(7):1432-5. doi: 10.1681/ASN.2009030282. Epub 2009 May 14. J Am Soc Nephrol. 2009. PMID: 19443632 No abstract available.
• Hemodialysis therapy in the United States: what is the dose and does it matter?

  Held PJ, Carroll CE, Liska DW, Turenne MN, Port FK. Held PJ, et al. Am J Kidney Dis. 1994 Dec;24(6):974-80. doi: 10.1016/s0272-6386(12)81108-5. Am J Kidney Dis. 1994. PMID: 7985679 Review.
• V. Patient mortality and survival in ESRD.

  [No authors listed] [No authors listed] Am J Kidney Dis. 1999 Aug;34(2 Suppl 1):S74-86. doi: 10.1053/AJKD034s00074. Am J Kidney Dis. 1999. PMID: 10431004 No abstract available.
• Contextual issues in comparing outcomes and care processes for ESRD patients around the world.

  Reddan D, Szczech LA, Conlon PJ, Owen WF Jr. Reddan D, et al. Blood Purif. 2001;19(2):152-6. doi: 10.1159/000046933. Blood Purif. 2001. PMID: 11150802 Review. No abstract available.
• Dialysis update in Japan.

  Sanaka T. Sanaka T. Ther Apher Dial. 2006 Aug;10(4):303-4. doi: 10.1111/j.1744-9987.2006.00398.x. Ther Apher Dial. 2006. PMID: 16911181 No abstract available.